Imlunestrant vs Elacestrant: MOA and Clinical Trial Differences | Oncology Nursing News
Imlunestrant vs Elacestrant: MOA and Clinical Trial Differences | On…
4 months ago
oncnursingnews.com
The Role of Elacestrant in ER /HER2– Advanced Breast Cancer Harboring ESR1 Mutations | OncLive
The Role of Elacestrant in ER /HER2– Advanced Breast Cancer …
1 month ago
onclive.com
Dr Bardia on the Investigation of Elacestrant vs Endocrine Therapy in ER Early Breast Cancer | OncLive
Dr Bardia on the Investigation of Elacestrant vs Endocrine Therapy …
3 weeks ago
onclive.com
Oral SERDs in HR Positive Breast Cancer: Current Role and Patient Selection for Elacestrant | OncLive
Oral SERDs in HR Positive Breast Cancer: Current Role and Patient …
1 month ago
onclive.com
New menopause drug to target hot flashes without hormones gets FDA approval
New menopause drug to target hot flashes without hormones gets FD…
4 months ago
abc30.com
ADELA Study - Elacestrant Everolimus vs. Elacestrant in ER /HER2- aBC With ESR1-Mutated Tumors Progressing on ET CDK4/6i
ADELA Study - Elacestrant Everolimus vs. Elacestrant in ER /…
301 views9 months ago
vumedi.com
Understanding Estrogen Replacement Therapy for Menopausal Dryness
0:58
Understanding Estrogen Replacement Therapy for Menopa…
73.2K viewsJan 7, 2023
TikTokmenopausedoctor
Phase 3 EMERALD Study of Elacestrant | Targeted Oncology - …
8 months ago
targetedonc.com
The Role of Elacestrant in Breast Cancer | OncLive
Jan 30, 2024
onclive.com
Impact of Prior Treatment, ESR1 Mutations, and PI3K Pathway on E…
191 viewsDec 17, 2024
vumedi.com
3:07
The EMERALD Trial: Elacestrant in Patients with HR+, HER2- Advance…
1 week ago
onclive.com
The Role of Elacestrant in HR /HER–- mBC: Insights From the E…
8 months ago
onclive.com
EMERALD subgroup analysis: Elacestrant in endocrine-sensitiv…
Nov 25, 2024
targetedonc.com
18:01
Elacestrant Combinations in ER /HER2- Locally Advanced or Metas…
5 months ago
onclive.com
EMERALD: Elacestrant in ER /HER2- Advanced Breast Cancer | OncLive
Jan 23, 2024
onclive.com
SABCS 2022 EMERALD Phase 3 Trial: Elacestrant and PFS in ER+/…
2.4K viewsJan 10, 2023
vumedi.com
1:07
Tumori: oncologa Del Mastro, 'elacestrant passo avanti in cura c…
1 month ago
MSNAdnkronos
Elacestrant Combinations in Patients With ER /HER2- Locally A…
144 views5 months ago
vumedi.com
Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CA…
284 viewsMar 4, 2024
vumedi.com
ER metastatic breast cancer: Key insights on elacestrant from the la…
11 months ago
apple.com
All-Oral Elacestrant Combos Offer “Tremendous” Benefits in Breast …
2 months ago
cancernetwork.com
2:01
Real-World Data Reveal Longer PFS With Elacestrant in Breast Cancer …
1 week ago
targetedonc.com
Dr. Bardia on Elacestrant in ER+/HER2– Metastatic Breast Can…
3 weeks ago
onclive.com
The EMERALD Trial: Elacestrant Mechanism of Action, Study Desig…
Nov 9, 2022
targetedonc.com
Tumore: elacestrant nuova terapia in aiuto a pazienti con carcinoma …
Jun 20, 2024
Il Sole 24 ORE
Dr Kaklamani on the Effects of VAF on Elacestrant Outcomes in ER Br…
Dec 11, 2024
onclive.com
Kaklamani on Elacestrant for CDK4/6 Inhibitor-Naive ER Breast …
Dec 12, 2024
targetedonc.com
Considering Elacestrant in ESR1 Breast Cancer After CDK4/6 Inhibi…
Feb 17, 2025
targetedonc.com
SABCS 2022 EMERALD Phase 3 Trial Updated Results by Duration …
1.7K viewsDec 14, 2022
vumedi.com
Dr. Lin on the Advantage of Elacestrant in ESR1-Mutated Brea…
Jun 14, 2022
onclive.com
See more videos
Static thumbnail place holder